MENU
SUPN
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Supernus Pharmaceuticals (SUPN) Earnings Date & Reports
Supernus Pharmaceuticals Inc is a specialty pharmaceutical company... Show more
Industry: #Pharmaceuticals Other
A.I. Advisor
published Earnings
SUPN is expected to report earnings to rise 12.99% to 68 cents per share on November 10
Q3'26
Est.
$0.68
Q1'26
Beat
by $0.41
Q4'25
Missed
by $0.48
Q3'25
Missed
by $0.94
Q2'25
Missed
by $0.08
The last earnings report on May 05 showed earnings per share of 60 cents, beating the estimate of 19 cents. With 49.27K shares outstanding, the current market capitalization sits at 2.74B.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information
General Information
a developer for the treatment of central nervous system
Industry PharmaceuticalsGeneric
Profile
Details
Industry
Pharmaceuticals Other
Address
9715 Key West Avenue
Phone
+1 301 838-2500
Employees
778
Web
https://www.supernus.com